FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Prednisolone Acetate 1% Ophthalmic Suspension
Status: Discontinuation
»Therapeutic Categories: Ophthalmology

Expand all

Novartis (New 08/22/2018)

Company Contact Information:
888-669-6682

Presentation Posting Date Related Information
5mL in 1 Bottle (NDC 0065-0638-27) 08/22/2018 Novartis Pharmaceuticals has made a business decision to permanently discontinue the product Omnipred 1% Ophthalmic Suspension, 5mL.
10mL in 1 Bottle (NDC 0065-0638-25) 08/22/2018 Novartis Pharmaceuticals has made a business decision to permanently discontinue the product Omnipred 1% Ophthalmic Suspension, 10mL.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English